	Liver Fibrosis and Purinergic Signaling: Autocrine-Paracrine Role of ATP in Liver Damage. Int J Mol Sci Ramos-Rosillo BV, Mata-Martínez E, Díaz-Muñoz M, Vázquez-Cuevas FG. PMID: 42450299 [PubMed - indexed for MEDLINE]
	Transcriptomic Identification of Diagnostic Biomarkers for Alcohol-Associated Liver Cirrhosis: Integration of Population-Level Epidemiology with Multi-Cohort Transcriptomic Analysis. Int J Mol Sci Wang H, Ding W, Zhang L, Xu M, Sui J. PMID: 42450082 [PubMed - indexed for MEDLINE]
	Evaluation of Kidney Function in Cirrhosis: Methods and Pitfalls. Diagnostics (Basel) Gil-Lopez F, Parikh N, Mai M, Chirila R, Wadei HM. PMID: 42449869 [PubMed]
	Machine Learning Predicts Treatment Response and Prognostic Pathways From Whole-Blood Transcriptome in Primary Biliary Cholangitis. Liver Int Syed H, Sun N, Waly D, Verma V, Smith M, Shapiro D, Erickson M, Siminovitch K, Swain M, Osman MS, Mason AL. PMID: 42449558 [PubMed - indexed for MEDLINE]
	Delayed Mortality After Successful Hemostasis in Cirrhotic Upper Gastrointestinal Bleeding: A Prospective Observational Study. Clin Res Hepatol Gastroenterol Badwei N, El-Folly RF, Abdu Hemdan HA, Mohamed Wassif GO, Yousry Kabiel WA, Marzouk Biomy MA. PMID: 42448148 [PubMed - as supplied by publisher]
	Revisiting two-stage models of chemically-induced cirrhosis-associated hepatocarcinogenesis in rodents: methodological and histopathological approaches. J Mol Histol da Fonseca ARB, de Magalhães Junior PFC, Barbisan LF. PMID: 42446627 [PubMed - indexed for MEDLINE]
	Best Practice: Implementation of Liver US Shear-Wave Elastography in Clinical Practice. Radiology Parameswaran M, Baikpour M, Hunt DT, Orlowski M, Samir AE, Pierce TT. PMID: 42446359 [PubMed - indexed for MEDLINE]
	Rifaximin Plus Probiotics Reshape Gut Microbiota, Serum Propionate, and Mucosal Immunity in Cirrhosis-Related Hepatic Encephalopathy Microbiota-Immune Remodeling in HE. Can J Gastroenterol Hepatol Wang Y, Zhu H, Wang S, Hu D, Xu M, Lee L, Lee D. PMID: 42444028 [PubMed - indexed for MEDLINE]
	Effectiveness of Risk-Stratified Evidence-Based Nursing at Different Time Points in Cirrhosis with Upper Gastrointestinal Bleeding. J Vis Exp Zhang L, Gu Y, Xi S, Yan L, Liu X, Yang S, Zhang X. PMID: 42441707 [PubMed - indexed for MEDLINE]
	[Hepatic Overlap Syndrome: Primary Sclerosing Cholangitis and Primary Biliary Cholangitis. Case Review]. Rev Med Chil Aronsohn F, Poniachik J. PMID: 42441677 [PubMed - indexed for MEDLINE]
	Machine learning modeling to predict HCC locations in cirrhotic patients undergoing MRI - a proof-of-concept study. Abdom Radiol (NY) Gaddum O, Zeevi T, Dai W, Lin M, Thomas S, Tefera J, Sobirey R, Matuschewski NJ, Gross M, Abosabie SA, Abosabie SAS, Gebauer B, Savic LJ, Madoff DC, Duncan JS, Chapiro J. PMID: 42440113 [PubMed - as supplied by publisher]
	Microwave ablation of malignant liver lesions: Does the presence of cirrhosis affect the diameter of the ablation zones? A retrospective comparative study from a single institution. Br J Radiol Shaygi B Dr, Burger R Dr, Reed W, Ashraf N Dr, Weston-Petrides G Miss, Puttick T Dr, Hamed A Professor, Luigi R Dr, Peddu P Dr. PMID: 42439537 [PubMed - as supplied by publisher]
	Impact of the Number of Remaining Natural Teeth on Decompensation and Survival in Patients With Compensated Liver Cirrhosis. Hepatol Res Nakatani T, Namisaki T, Takaya H, Inoue T, Shibamoto A, Iwai S, Oyama M, Hanatahi J, Nishimura N, Tsuji Y, Fujinaga Y, Sato S, Nishimura N, Kitagawa K, Kaji K, Mitoro A, Akahane T, Yoshiji H. PMID: 42438897 [PubMed - as supplied by publisher]
	Response to "Comment on 'Using Serum Creatinine-To-Cystatin C Ratio to Predict Sarcopenia in Patients With Liver Cirrhosis'". Hepatol Res Shibamoto A, Namisaki T, Takami M, Masuda H, Inoue T, Iwai S, Asada S, Tsuji Y, Fujinaga Y, Sato S, Nishimura N, Kitagawa K, Takaya H, Kaji K, Mitoro A, Asada K, Yoshiji H. PMID: 42438212 [PubMed - as supplied by publisher]
	Drug Development for MASH-Related Compensated Cirrhosis: Past, Present and Future. Liver Int Zeng RQ, Shao YX, Lin RT, Shen XT, Sun QM, Xin X, Liu P, Fan JG, Hu YY, Feng Q. PMID: 42438128 [PubMed - indexed for MEDLINE]
	The Use of FGF21 Analogues in MASH and MASH Cirrhosis - Metabolic Master Regulators or Liver-Specific Mechanisms? (â˜†). JHEP Rep Holleboom AG, Schattenberg JM. PMID: 42435974 [PubMed - as supplied by publisher]
	Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites. United European Gastroenterol J Pompili E, Zaccherini G, Nardelli S, Piano S, Alessandria C, Neri S, Foschi FG, Levantesi F, Airoldi A, Simone L, Svegliati-Baroni G, Fagiuoli S, Marra F, Cozzolongo R, Iannone G, Biselli M, Riggio O, Angeli P, Bernardi M, Baldassarre M, Caraceni P, ANSWER Study Investigators. PMID: 42435328 [PubMed - indexed for MEDLINE]
	Comparative Assessment of Salivary Neutrophil Gelatinase-Associated Lipocalin Levels (NGAL) Among Subjects With Periodontitis, Liver Cirrhosis, and Healthy Individuals: A Cross-Sectional Study. Cureus Dongare SS, Zope SA, Suragimath G, Varma S, Kale AV. PMID: 42434656 [PubMed]
	Association of fat-related metabolic indices with MASLD and liver fibrosis: a cross-sectional analysis of NHANES 2017-2020. Medicine (Baltimore) Shen N, Wei Q, Zhao J, Cai J. PMID: 42432919 [PubMed - indexed for MEDLINE]
	Albumin-to-creatinine ratio as non-invasive marker for prediction of non- bleeding esophageal varices. a cross-sectional observational study. BMC Gastroenterol Mousa N, Elmetwalli A, Abdelsalam M, Wahba M, El-Wakeel N, Mansour M, Selim M, Diasty M, Abdelkader E, El-Assmy A, Abdelaziz M, El-Assmy A, Alhawarey A. PMID: 42432532 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 38908

Page 1 of 1946



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy